HomeCompareCRSQ vs MRK

CRSQ vs MRK: Dividend Comparison 2026

CRSQ yields 34482.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRSQ wins by $1.181212426446909e+22M in total portfolio value
10 years
CRSQ
CRSQ
● Live price
34482.76%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.181212426446909e+22M
Annual income
$11,745,121,413,034,463,000,000,000,000.00
Full CRSQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CRSQ vs MRK

📍 CRSQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRSQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRSQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRSQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRSQ
Annual income on $10K today (after 15% tax)
$2,931,034.48/yr
After 10yr DRIP, annual income (after tax)
$9,983,353,201,079,293,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CRSQ beats the other by $9,983,353,201,079,293,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRSQ + MRK for your $10,000?

CRSQ: 50%MRK: 50%
100% MRK50/50100% CRSQ
Portfolio after 10yr
$5.906062132234545e+21M
Annual income
$5,872,560,706,517,231,000,000,000,000.00/yr
Blended yield
99.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CRSQ
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRSQ buys
0
MRK buys
0
No recent congressional trades found for CRSQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRSQMRK
Forward yield34482.76%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.181212426446909e+22M$56.8K
Annual income after 10y$11,745,121,413,034,463,000,000,000,000.00$9,798.13
Total dividends collected$1.1807719073916433e+22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRSQ vs MRK ($10,000, DRIP)

YearCRSQ PortfolioCRSQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$3,458,976$3,448,275.86$11,206$366.19+$3.45MCRSQ
2$1,118,421,008$1,114,719,903.99$12,650$502.35+$1118.41MCRSQ
3$338,049,201,182$336,852,490,703.46$14,407$694.19+$338049.19MCRSQ
4$95,516,486,855,497$95,154,774,210,231.90$16,585$967.82+$95516486.84MCRSQ
5$25,229,468,328,403,976$25,127,265,687,468,590.00$19,342$1,363.89+$25229468328.38MCRSQ
6$6,229,844,577,274,484,000$6,202,849,046,163,091,000.00$22,913$1,947.19+$6229844577274.46MCRSQ
7$1,438,117,137,026,070,000,000$1,431,451,203,328,386,500,000.00$27,662$2,823.89+$1438117137026070.00MCRSQ
8$310,361,914,951,373,900,000,000$308,823,129,614,756,000,000,000.00$34,159$4,173.35+$310361914951373888.00MCRSQ
9$62,619,487,322,080,650,000,000,000$62,287,400,073,082,670,000,000,000.00$43,337$6,308.80+$62619487322080649216.00MCRSQ
10$11,812,124,264,469,090,000,000,000,000$11,745,121,413,034,463,000,000,000,000.00$56,776$9,798.13+$1.181212426446909e+22MCRSQ

CRSQ vs MRK: Complete Analysis 2026

CRSQStock

Corporate Restaurant Concepts, Inc. provides management and consultation services for restaurants. It operates two divisions: Management group and CRC partnership program. The company's Management group division develops and manages a portfolio of casual dining restaurants. Its CRC partnership program division provides products and services to company-managed and independently operated restaurants. The company's restaurants provide Mexican foods. Its products and services include food cost evaluation, labor cost control, payroll and benefits management, human resources, employee training and retention, and credit card processing, as well as menu design, sales and marketing, Website design and management, and customer loyalty programs. Corporate Restaurant Concepts, Inc. was incorporated in 2008 and is based in Overland Park, Kanas.

Full CRSQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CRSQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRSQ vs SCHDCRSQ vs JEPICRSQ vs OCRSQ vs KOCRSQ vs MAINCRSQ vs JNJCRSQ vs ABBVCRSQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.